Suwon-si, South Korea

Key An Um

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 10.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Kyunggi-do, KR (2014)
  • Suwon-si, KR (2008 - 2015)

Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Key An Um: Innovator in Pharmaceutical Composition

Introduction

Key An Um is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for medical use. With a total of 4 patents to his name, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Key An Um's latest patents include a gonadotropin-releasing hormone receptor antagonist and a stable pharmaceutical composition containing docetaxel. The first patent discloses compounds that are useful as gonadotropin-releasing hormone receptor antagonists. The second patent relates to a stable pharmaceutical composition for injection containing docetaxel, which is prepared by dissolving docetaxel in distilled water after mixing it with cyclodextrin and a water-soluble polymer. This innovative method enhances the storage stability of the medication compared to conventional formulations.

Career Highlights

Key An Um is currently associated with Sk Chemicals Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Key An Um has collaborated with notable colleagues, including Jae-Sun Kim and Nam Kyu Lee. These partnerships have contributed to the successful development of his innovative patents.

Conclusion

Key An Um is a distinguished inventor whose work in pharmaceutical compositions demonstrates his commitment to improving medical treatments. His contributions are poised to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…